UNICREDIT BANK/CALL/NOVO-NORDISK B/600/0.2/18.12.24 | Market Closed - BOERSE MUENCHEN 15:46:18 2024-05-31 EDT | ||
| 8.97 EUR | +1.70% |
|
| 1 month | +5.28% | ||
| 3 months | +35.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 8.97 | +1.70% |
| 24-05-30 | 8.82 | +0.46% |
| 24-05-29 | 8.78 | -0.90% |
| 24-05-28 | 8.86 | -1.12% |
| 24-05-27 | 8.96 | -3.55% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 03:46 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
UniCredit
|
| WKN | HC7P39 |
| ISIN | DE000HC7P391 |
| Date issued | 2023-06-26 |
| Strike | 600 kr |
| Maturity | 2024-12-18 (199 Days) |
| Parity | 5 : 1 |
| Emission price | 1.73 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.5 € |
|---|---|
| Lowest since issue | 1.3 € |
| Delta | 0x |
| Omega | 0.000000 |
| Premium | 0x |
| Gearing | 0x |
| Moneyness | 1.546 |
| Difference Strike | -327.3 kr |
| Difference Strike % | -54.55% |
| Intrinsic value | 8.768 |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3
DKK
Average target price
917.2
DKK
Spread / Average Target
-1.09%
- Stock Market
- Warrants
- Warrant
